Data from National Survey of Health Care Providers Provides Insights on Opioid Prescribing and Influences on Prescriber Decisions
Westat researchers have published new findings on the influence of opioid education and marketing on prescriber decisions and prescribing patterns.
Findings from a national survey of health care providers include:
- Opioid Education and Prescribing Practices: Results from a National Survey of Health Care Providers, published in the Journal of the American Board of Family Medicine
- What Influences Healthcare Providers’ Prescribing Decisions? Results from a National Survey, published in Research in Social and Administrative Pharmacy
Authors include Westat’s Simani Price, Ph.D., Associate Director; Lou Rizzo, Ph.D., a Senior Statistician; Saloni Sapru, Ph.D., a Senior Study Director; and Amie C. O’Donoghue, Ph.D., and Kathryn J. Aikin, Ph.D., of the Office of Prescription Drug Promotion Research within the Center for Drug Evaluation and Research at the Food and Drug Administration.
“There is a lack of national data about health care providers’ exposure to opioid educational information and industry promotions,” explains Dr. Price. “These findings provide national estimates for exposure and also provide evidence that opioid education can reduce opioid prescribing and the various methods used by industry to influence prescriber decisions.”